Engerix B

Engerix B is a vaccine designed to prevent hepatitis B infection. It contains hepatitis B surface antigen (rDNA) and alum adjuvant. This vaccine is administered intramuscularly or subcutaneously.

Engerix B is used to protect against hepatitis B virus infection. It is typically recommended for individuals at risk of exposure, such as healthcare workers, travelers to regions with high infection rates, and those with chronic liver disease. The vaccine works by stimulating the body's immune response to develop antibodies against the hepatitis B virus.

Common effects of Engerix B may include soreness at the injection site, mild fever, and fatigue. These effects are usually temporary and resolve on their own. Severe reactions are rare but can occur, and medical attention should be sought if they do.

Engerix B should be administered with caution in individuals with a history of severe allergic reactions to any component of the vaccine. It is important to inform healthcare providers about any allergies or medical conditions before receiving the vaccine. Pregnant or breastfeeding individuals should consult their healthcare provider before use.

Engerix B may interact with certain medications or other vaccines. It is advisable to discuss all current medications and recent vaccinations with a healthcare provider before receiving Engerix B. Alcohol and other substances that affect the immune system may also influence the vaccine's effectiveness.